AFT Pharmaceuticals develops, licenses, and sells a range of medical products globally. We believe that the key to improving people's health lies in innovation.

What’s our company vision?

It’s pretty simple really, our vision is to develop innovative products that help people.
We do this by looking at healthcare needs, understanding how those needs are changing, and how we can provide treatment options that work.

Our success as a company has been built on seeing opportunities in areas that others have missed.

Our guiding principle is to do things better than they've have been done before. Whether it’s developing products with multiple-benefits, creating drug delivery devices that produce less discomfort for patients, or getting lower-cost drugs to people with rare diseases, we're always focused on improving the status quo.

This has allowed us to grow as a company, and crucially, to help meet the health needs of people in Australasia and in more recent years, around the globe.



Graph depicts AFT Pharmaceuticals office locations in New Zealand, Australia and Malaysia.

We started small. But we dreamed big.

Back in 1997, husband and wife team Hartley and Marree Atkinson hit the road selling products direct to pharmacies. AFT Pharmaceuticals was formed with a big dream in mind.

In Australasia, our product line now extends to over 130 prescription and non-prescription products. We have offices in Singapore, Kuala Lumpur, Sydney and Auckland (our HQ). We export or license our products to over 125 countries. Plus our Orphan Drugs Foundation provides access to lower cost pharmaceuticals for people with rare diseases within South East Asia and the Pacific.

This success has been built on research and development. R&D is more than corporate speak for us. It’s at the heart of what we do, whether it’s developing new products, or improving existing ones. It’s also due to the fact that we are close to the market. Because we sell our own products we are constantly looking for changes in health needs and how we can fill gaps that emerge.

Our ideas, our researchers, our specialist drug development programmes, and the international experts we partner with have allowed us to grow year on year. It’s how we’ve managed to forge a place on the world stage in the extremely competitive pharmaceutical industry.

We're proud of our past achievements. We’re ambitious for the future.


Graph depicts AFT Pharmaceuticals global product and device manufacturing partners.

Our ability to understand healthcare markets, and to take advantage of niche opportunities, means AFT Pharmaceuticals has experienced consistent annual sales growth.

“We’ve invested a lot of money on R&D. That’s where the real bang is. At the moment we’re spending about $4m every year and that doesn’t include staff, that’s just straight spend on clinical trials and product development”.


AFT growth graph 01

“By morning tea on the first day of the year – January 1st – the US exceeds New Zealand’s total drug sales for the year. By the afternoon on the second day of the year, they pass Australia. This gives you an idea of the scope of the global drug market and the potential for our company offshore. But we will continue to drive it from down under.”